Dominant-negative Effects ofCOL7A1Mutations Can be Rescued by Controlled Overexpression of Normal Collagen VII

Mechanisms of Fibroblast Cell Therapy for Dystrophic Epidermolysis Bullosa: High Stability of Collagen VII Favors Long-term Skin Integrity

(2009) Johannes S Kern et al.   MOLECULAR THERAPY

Collagen VI glycine mutations: Perturbed assembly and a spectrum of clinical severity

(2008) Rishika A. Pace et al.   ANNALS OF NEUROLOGY

Recombinant Collagen Studies Link the Severe Conformational Changes Induced by Osteogenesis Imperfecta Mutations to the Disruption of a Set of Interchain Salt Bridges

(2008) Ke Xu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Characterization of Molecular Mechanisms Underlying Mutations in Dystrophic Epidermolysis Bullosa Using Site-directed Mutagenesis

(2008) David T. Woodley et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Supramolecular Interactions in the Dermo-epidermal Junction Zone

(2008) Daniela Villone et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy

(2008) Anja Fritsch et al.   JOURNAL OF CLINICAL INVESTIGATION

SMaRT Technology Enables Gene Expression Repair in Skin Gene Therapy

(2008) Ulrich R. Hengge   JOURNAL OF INVESTIGATIVE DERMATOLOGY

The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB

(2008) Jo-David Fine et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY